Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(15.1%),New Enterprise Associates 15, L.P.(15.1%), etc.

SEC · Aug 24, 2022 05:18

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(15.1%),New Enterprise Associates 15, L.P.(15.1%), etc.

Risk Disclaimer